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ABSTRACT 
 
Pseudo-protein is  a name used to describe an amino acid based poly(ester amide)s (aa-
PEA). One possible application of pseudo-protein is as a drug delivery coating. To form a 
drug-delivery micelle, positively charged Phenylalanine-Arginine-PEA (Phe-Arg-PEA) 
was mixed with negatively charged hyaluronic acid (HA). HA, a natural polysaccharide 
abundant in human skin and the extracellular matrix, binds to the CD44 glycoprotein 
receptor on surface of cancer cells and is therefore a possible pathway to the  development 
of  precisely targeted cancer treatments. Nanoparticle micelles with smaller diameters are 
more efficient in the drug delivery process. In this study we attempted to find and adjust 
the ratio of hyaluronic acid to Phe-Arg-PEA to form nanoparticles of optimized size. 
Preliminary data on drug loading capability of sample ratio 3:2 were also summarized.
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CHAPTER 1 – INTRODUCTION 
 
 
INTRO TO THE  MECHANISTIC BACKGROUND SUPPORTING  THIS WORK 
Nanoparticle micelles encapsulate drugs and deliver them to cancer cells through the blood 
stream. This work reports initial efforts at producing encapsulations using a synthetic AA-
PEA (also known as a “pseudo-protein”) in Professor Chu’s lab.  The choice of Phe-Arg-
PEA is convenient as it  provides an easy way to provide positive charges (on the 
guanidinyl side chains of Arg) which  will be useful to interact with the anionic HA   
When these two long-chain molecules are mixed in solution the counterbalancing charges 
allow them to intimately interact and under proper conditions to form a nanoparticle 
micelle.  While the resulting nanoparticle micelle is schematically represented as double 
layered (Supplement 1) but realistically a sphere with three or more mingled layers. In the 
future, the micelles should be tested on crosslinking, stability, toxicity in vitro, and so on. 
(Figure 1) 
Figure 1. Mechanism of drug delivery by HA-Phe-Arg-PEA. 
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AN INTRODUCTION TO AA-PEA 
AA-PEAs are biodegradable amino acid-based poly(ester amide)s synthesized from 
polymerization of different amino acids, diacids, diesters, or diols (Fig. 2) Theoretically 
any amino acid could be chosen as a component, which enables a big pool of upgradable 
products.  Possible merits of specific choices are discussed in what follows, from its 
analogous role to proteins in human body, which will also clarify why we choose to refer 
to this class of artificial bio-inspired polymers as pseudo-proteins. 
Figure 2. The chemical structure of the repeating unit of an example pseudo-protein, Phe-
Arg-Poly(ester amide). Amino acids, diacids (Y), diols (X), amide bonds, and ester bonds 
are the main components in an aa-PEA, as defined by Chu. 
 
Pseudo-proteins and pseudo-protein-properties 
One essential similarity is that our PEA’s are enzyme-degradable. Normal peptides are 
individual amino acids covalently linked through amide bonds. aa-PEA is distinctive in 
that within one repeating unit there are two amino acids, both ester and amide bonds, diols 
and dicarboxylic acids. For example, in this study, the aa-PEA used is Phe-Arg-PEA. The 
ester and amide bonds are sites that are biodegradable by enzymes like alpha-
chymotrypsin, just as what they do to normal proteins, and the remaining constituents  can 
 3 
be returned to the cellular matrix where they can activate biochemical processes including 
macrophages which benefit wound healing as well.  This satisfies one important 
requirement--which is the non-toxic biocompatibility of a biomaterial. 
 
AA-PEA can be synthesized with essentially any amino acids incorporated into the  
backbone chain. The common twenty amino acids, with side chains that are either charged, 
polar, and/or aromatic, offer a wide range of functionality which can be used to 
consciously design properties into the synthetic polymer. The ring in proline could provide 
spatial obstacle. The thiol in cysteine could offer the reactivity of cross-linking. In this 
study, arginine offers cationic affinity in the electrostatic self-assembly process of the 
synthetic micelles. The aromatic ring in phenylalanine could help establish a hydrophobic 
layer against drugs - at inner side of the synthetic micelles to avoid drug leaking or 
unsteady encapsulation in the process. 
 
AA-PEA could provide advanced tumor or cancer cell targeted treatments. While surgery, 
radiation, or chemotherapy are costly in terms of time, energy or money, and at the same 
time burdening the whole body, aa-PEA could be used to develop a precise targeted 
therapy to the tumors cost-efficiently. 
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WHY HYALURONIC ACID? 
 
Hyaluronic acid is a natural polysaccharide with repeating unit of two sugars, D-
glucuronic acid and N-acetyl-L-glucosamine, linked through ß-1, 4 and ß-1, 3 (Fig. 3). It is 
conserved evolutionarily and abundant in the extracellular matrix, from prokaryotes to 
eukaryotes, and is usually present as a high molecular weight polymer ranging from 
kiloDaltons to hundreds of kiloDalton. In human bodies, 50-60% of total HA composes the 
dermis, epidermis (Prasad N.Sudha, 2014) (See Fig. 4) and exists in virtually all other 
connective tissues and fluids (Laurent, 1989).  
 
Figure 3. The chemical structure of the repeating unit of hyaluronic acid. The sugar on the 
left is glucuronic acid and the sugar on the right is acetylglucosamine. HA is usually 
present in large molecular weights, as in long random chains of huge number of repeating 
units. 
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Figure 4. Location of HA in epidermis and dermis (circled) in human skin. 
 
HA has been widely exploited in cosmetics, tissue regeneration, and possibly other 
fields of human body repair. As an elastic, hydrating, rejuvenating material, it is 
considered ideal for filling wrinkles and correcting scars on human bodies (Narins RS, 
2003). Histological evidence in vivo was observed in rats, where non-animal-derived HA 
filler subcutaneously injected allowed ingrowth of tissue after fibroblast proliferation and 
migration, collagen formation, and growth of fat tissues. Hyaluronic acid can also be used 
to make synthetic hydrogels. In 2011 Prestwich fabricated a synthetic biograde ECM 
hydrogel as a clinical combination product after preparation using both microspinning and 
electrospraying techniques. The HA-based ECM was injected into rabbit femoral articular 
cartilage and was able to repair damages through enhancing endogenous natural repair 
mechanisms (D.Prestwich, 2011). In another study, one of the deviations of HA could 
repair spinal cord injury through cell delivery (Kubinova, 2018). Scientists modified HA 
into HA-hydroxyphenyl-RGD containing the integrin-binding peptide arginine-glycine-
aspartic acid, and fibrinogen in the solution. Human stem cell-derived mesenchymal cells 
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were cultured and proliferated in this solution to spur growth as a treatment. Rats with 
hemisected vertabra subjected to the gel injection application were observed with 
migration of astrocytes, infiltration of newly generated blood vessels into the treatment 
area, and production of oligodendrocyte within it, the data of which shows a very 
promising future of a spinal cord injury repairing or restoration material.  
  
HA is involved in a variety number of physiological processes which appear linked to 
development of cancer cells. In angiogenesis, the growth of new capillary vessels,  HA 
specifically binds to the CD44 glycoprotein receptors which regulate the progression and 
metastasis of cancer cells on the surface of endothelial cells, and further stimulate their 
proliferation and migration (Linda T. Senbanjo and Meenakshi A. Chellaiah, 2017; J A P 
Gomes, 2004;D. C. West and S. Kurnar , 1989). HA also binds to the hyaluronan-mediated 
motility receptor HMMR (also known as CD168) which is a protein in breast tissue and 
potentially associated with BRAC1 and BRAC2 proteins in breast cancers in human 
bodies (NCBI, n.d.). Thus HA is involved in carcinogenesis and tumorigenesis as it is 
involved with both CD44 and CD168.  The former has been shown to be a biomarker not 
just in breast cancer but in multiple other types of cancer cells, including in leukemia, 
pancreatic cancer, melanoma, prostate cancer, and others.   HA’s strong affinity for CD44 
makes it a desirable component in building a precise nanoscale drug delivery cargo, which 
is the main reason why it was chosen in this study.  
 
In this study, HA has been utilized as an outside coating layer of nanoparticles where the 
positive charged HA molecules in solution can form with aa-PEA electrostatically into a 
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micelle-like structure. Potential drugs inside the micelles could be delivered to cancer cells 
or tumor cells using this polymer nanoparticle cargo delivery, with the HA sheathing 
improving the access of the drug molecules to the cell interior as HA has complex 
rheological characteristics includes steady shear rates and relaxation time when expressed 
in different molecular sizes and concentrations (A. García-Abuín, 2011; Mathew Nicholls, 
2018). 
  
 8 
CHAPTER 2 
 
MATERIALS AND METHODS 
 
Materials 
 
Hyaluronic acid stored at 4 °C was dissolved in a mixed solution of Milli Q water and 
Dimethyl-sulfoxide (DMSO). Though HA dissolves in water alone, DMSO is added at 
ratio 1 : 1 v/v for better compatibility with the PEA to be added later. The solution was 
thoroughly stirred at room temperature after dissolution.  
 
Phe-Arg-PEA was synthesized in C.C. Chu’s lab. It was dissolved in DMSO before 
mixing with HA.  Subsequently aa-PEA in DMSO solution was added into HA in 1:1 
solution of water and DMSO (v/v), drop by drop while mixing and was fully stirred for at 
least one hour in the bench.  
 
Gambogic acid was stored at -20 ℃ in solid form and dissolved in DMSO to 20 mg/ml 
prior to use. It is a potential anti-cancer candidate as it was found to possess anti-
inflammatory effects in rats. GA also suppresses the mRNA expression of survivin. As 
survivin is a highly expressed marker of cancer and suppresses the apoptosis of cancer 
cells, GA’s downregulation of its expression could have anti-cancer effects; in this work, 
its efficacy is not yet important as we are using it as a place-holder for whatever potential 
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drug might be developed. It was slowly added into newly mixed Phe-Arg-PEA solutions at 
room temperature before being mixed into HA solutions. 
 
Dialysis and filtration 
 
Well-mixed solutions with different portions of HA and aa-PEA were transferred into 
dialysis membrane sacks and were placed into a 1 L beaker filled with DI water. The water 
was stirred. By utilizing the principle of dialysis, DMSO would be extracted from the 
solutions in the sack and into the DI water in the beaker so as to achieve the balance of 
osmotic pressure across the membrane. While the molecules of DMSO are small enough to 
escape the porous membrane, the much larger aggregates of HA and aa-PEA polymers 
stay inside the membrane. The dialysis membrane was chosen from Thermo SnakeSkin™ 
Dialysis Tubing (10K MWCO). The dialysis process was carried out overnight, and 
underwent one or two times changes of water to thorough exchange DMSO out of the 
system. The extract was then vacuum-filtered to remove undissolved particles or random 
dust precipitated during the process.  
  
Thermo SnakeSkin™ Dialysis Tubing (10K MWCO) 
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Measurements of size and surface zeta potential 
 
  
Photo: Zetasizer Nano, CESI 
 
Samples were analyzed using the Zetasizer Nano instrument in Cornell Energy Systems 
Institute. In Zetasizer Nano, sizes (d in nm) of the nanoparticles in suspended solutions 
were characterized based on Dynamic Light Scattering technique, where the laser shooting 
through solutions were collected by the avalanche photodiode detector and processed to 
generate a function of light intensity and molecular size. To ensure the results are within 
measuring criteria, sample solutions were filtered and checked before transferring into the 
optical cells. The surface zeta potential is potential gap across the electrical double layers 
of the nanoparticles was measured to demonstrate that the solutes are forming in an 
expected way without contaminations, usually in negative charge as the bigger portion of 
positively charged HA is in the solution. When the portion of HA is larger in the mix, zeta 
potential of the nanoparticles is expected to be negative. If not, there may not be adequate 
number of nanoparticles present in the mix. 
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Measurement of drug loading percentage through ultraviolet absorbance 
 
Samples were adjusted to 1 M concentration, 1 ml volume before taken to measurement. 
By the light spectrometer, incident high energy UV light hit sample solutions in the 
transparent cell and transmitted light is measured. Using the Beer-Lambert law, percentage 
of sample drug loading were calculated from the trend line after UV absorbance was 
measured, 
A = εbC 
𝐴𝑠𝑡𝑑
𝐴𝑠𝑝
=  
𝜀𝑏𝐶𝑠𝑡𝑑
𝜀𝑏𝐶𝑠𝑝
 
⇒
𝐴𝑠𝑡𝑑
𝐴𝑠𝑝
=  
𝐶𝑠𝑡𝑑
𝐶𝑠𝑝
  
 
where Astd is peak absorbance of UV (a.u).; ε is molar absorptivity of GA in L mol/cm; b is 
optical path distance in cm; Cstd stands for concentration of GA loaded in samples; and Csp 
represents wanted concentrations of GA loading of samples.  
 
The standard curves were set to 5%, 25%, 40%, 50% and 75% (i.e. For the 5% standard 
curve, 50 µg GA powder was directly dissolved and vortexed in 1 ml solution with 1 : 1 
v/v DMSO and H2O, and  so on). And the trendline of drug loading ratio (%) versus UV 
absorbance (nm) was approximated. Results were summarized in the table. 
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Figure 5, 6. Plot of standard curves and estimated linear correlation equation of GA% and 
absorbance. Theoretically the line of estimation should start from (0, 0) as the Beer-
Lambert law shows direct proportionality between concentration and absorbance. The 
reasons for the small intercept at (0, 0.0486) could be improper calibration or instrumental 
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noise in practical. It was not the significant cause for the abnormal result in Table 4, where 
calculated drug% exceeded loaded drug% by 1.4%. As also explained in the result section, 
the error is highly possibly due to loss of Phe-Arg-PEA in the unstable drug-loading 
process where diameter of spheres were constantly changing. 
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CHAPTER 3 
 
RESULTS AND DISCUSSIONS 
 
Adjustment of HA-Phe-Arg-PEA ratios in the solutions 
 
A v/v ratio adjustment of HA to Phe-Arg-PEA was conducted first to see 1) If the 
synthesized Phe-Arg-PEA could form with HA under conducted experimental conditions; 
and 2) what ratio of HA : Phe-Arg-PEA would yield best results, which is a smallest 
diameter of the polymer nanoparticle. Data is shown in the following table.  
 
Table 1. Measured diameters (D) and plot of sample 1-7 of different v/v ratios. (* see 
Figure 7) 
sp# HA:PEA  D (nm) 
Z pot. 
(mV) 
1 5:1 168.2 -19.37 
2 3:1 1419.0 -28.07 
3* 3:1 157.4 -14.77 
4 2:1 197.3 -22.7 
5* 3:2 138.7 -18.9 
6 1:1 206.5 -20.7 
7 1:3 419.6 -15.6 
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Figure 7. Measured diameters (D) and plot of sample 1-7 of different v/v ratios. (* 
conducted in different time to other samples; Clear graph of size intensity distributions of 
sample #5 3:2 is in supplement.) 
 
From these results, sample 3:2 presented smallest diameters of polymer nanoparticles 
formed, while sample 3:1(sp# 2) had mostly undesired precipitations in the solution, 
whose diameters were ten times of usually expected ones, which should be due to 
contamination or mis manipulation. There was no obvious correlations between ratios with 
diameters or ratios with zeta potentials. 
 
To continue testing its drug loading capability, GA was loaded this time with a percentage 
of 5%, 10%, and 15%, corresponding to 0.7 mg, 1.4 mg, and 2.1 mg in the table for a 
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longitudinal comparison of drug loading capability (Table 3). As explained in the methods, 
drugs successfully loaded could be measured by UV spectrometer (see Table 4). 
 
Table 3. Third time results with extra GA drug loading 
HA : PEA  
HA 
(mg) 
PEA 
(mg) 
H2O 
(ml) 
DMSO 
(ml) 
Vtot 
(ml) 
Mix. 
mg 
Mix. 
conc. 
(M) 
GA 
(mg) 
Fin. 
conc. 
(M) 
3:2 10 4 1 1.8 2.8 14 5 
0.7 5.25 
1.4 5.5 
2.1 5.75 
 
Table 4. UV absorbance, diameter, and zeta potential results of the samples in table 3 and 
calculated drug loading percentage using the Beer-Lambert Law from absorbance. 
[GA] in 
Sample 
3 : 2 
GA (mg) Abs. Mass (µg) 
Drug 
loading % 
Size (nm) of 
first peak 
Average size 
(nm) 
5% 0.7 0.1240 34.265 3.40% 194.4 1214 
10% 1.4 0.3016 114.978 11.40% 124500 
15% 2.1 0.1636 52.285 5.30% 320.1 2230 
 
From Table 4, overall speaking the first time drug loading process yielded unstable results. 
From the size results, there were all increase in particle diameters. However, according to 
supplement peak intensity graphs, there were polydiversities in all samples, which 
indicated during the 2 min measurement time in the machine, there was dynamic 
descending and merging of nanoparticles in the solutions.  
 
It seems 10% GA in sample 3 : 2 yielded an abnormally large number after loading that 
was out of normal range, too different from data in sample 5% and 15%. Thus I suspect the 
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reasons could be unknown crystallization and thaw during lyophilization that unbalanced 
the system in some way. In Table 1 sample #2 (HA:PEA 3:1), there might be incomplete 
filtration. To avoid these, two layers of filter paper should be applied in filtration, and time 
of setting samples into vacuums could be shortened while keep samples on ice. And most 
importantly, handle the freeze drying process well, using multiple tubes for each sample. 
 
What to do in the future 
 
Besides those mentioned in the last section, in the future, larger total mass of samples 
should be used to confirm if there is variations on diameters. The same drug loading 
conditions in Table 3 & 4 should be set to sample of 1 : 1 for a horizontal comparison of it, 
as drug loading capability may not linearly relate to nanoparticle diameters.  
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Supplement 1. The ideal schematic structure of the synthetic polymer micelle nanoparticle, 
which has a double layer coating. The outer layer is the negatively-charged hyaluronic acid 
and the inner layer is the positively-charged Phe-Arg-PEA. 
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Supplement 2 (1): Size distribution graph of sample 3:2. 
The polymer micelle was stably formed before drug loading as Peak 1 takes up 96% 
intensity. After drug loading, as in supplement 2 (2), (3), formed bigger polymer micelles 
were unstable and polydiversed. The graph result of drug loading 10% show no peaks at 
all. So it was not presented here. 
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Supplement 2 (2): Size distribution graphs of sample 3:2 after 5% drug loading. 
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Supplement 2 (3): Size distribution graphs of sample 3:2 after 15% drug loading. 
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